Octarine

Company Overview

Snapshot

Founded in July 2017 by Shemer Schwarz, Haim Helman, and Adi Ashkenazi, Octarine operated with 11–50 employees. The company was acquired by VMware in May 2020, marking a significant exit in the cloud-native security space.

Business overview

Octarine developed an application-level security platform designed to secure businesses and data within cloud-native applications. Its core technology focused on providing visibility into microservices and enforcing policies to protect data in line with security and compliance objectives. The company's solutions aimed to prevent unauthorized activity and data exfiltration within cloud-native environments, serving the Cyber Security sector, specifically in Cloud Security and Application & Website Security.

Strategic signal

In May 2020, VMware announced its acquisition of Octarine, integrating the Kubernetes security startup into its Carbon Black portfolio. This acquisition signals VMware's strategic move to enhance its security offerings for cloud-native applications and Kubernetes environments, validating Octarine's technology and market relevance in a rapidly evolving cloud infrastructure landscape.

Company Intelligence Q&A

What was Octarine's exit event?

Octarine was acquired by VMware in May 2020. This acquisition led to the company's inactive status as it was integrated into VMware's operations.

When did Octarine release its open-source security scanning tool for Kubernetes?

In January 2020, Octarine released an open-source security scanning tool specifically designed for Kubernetes environments, enhancing its product offerings for cloud-native security.

Who were the co-founders of Octarine?

Octarine was co-founded by Shemer Schwarz, Haim Helman, and Adi Ashkenazi.

What is Octarine's primary focus in the market?

Octarine focuses on cloud-native application security, providing solutions to secure microservices and enforce data protection policies within cloud environments.

Which investors participated in Octarine's funding round in October 2017?

In October 2017, Octarine received funding from investors including Accel and Sorenson Capital.